— Know what they know.
Not Investment Advice

NUWE

Nuwellis, Inc.
1W: -18.2% 1M: -44.9% 3M: -54.4% YTD: -43.1% 1Y: -97.8% 3Y: -100.0% 5Y: -100.0%
$1.03
+0.02 (+1.98%)
After Hours: $0.99 (-0.04, -3.88%)
NASDAQ · Healthcare · Medical - Devices · $929745 · Alpha Radar Strong Sell · Power 29
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$0.9M
52W Range0.96-50.82
Volume147,997
Avg Volume2,220,591
Beta-0.01
Dividend
Analyst Ratings
1 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOJohn L. Erb
Employees38
SectorHealthcare
IndustryMedical - Devices
IPO Date2012-02-16
12988 Valley View Road
Eden Prairie, MN 55344
US
952 345 4200
About Nuwellis, Inc.

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Recent Insider Trades

NameTypeSharesPriceDate
McDonald David 7 $1.32 2026-02-24
McDonald David 416 $1.36 2026-02-24
Schultz Carisa 0 2026-01-28
Field Katharyn 0 2026-01-21
Grasso Mika 0 2026-01-21

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms